Dapagliflozin vs Durvalumab

## Dapagliflozin vs Durvalumab: Overview

This comparison examines the pharmacological differences between **Dapagliflozin** and **Durvalumab**.

## Mechanism of Action

**Dapagliflozin**: Selective SGLT2 inhibitor reducing renal glucose and sodium reabsorption.

**Durvalumab**: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

## Pharmacokinetics

**Half-life**: Dapagliflozin — 12.9 hours; Durvalumab — 17 days.

## Chemical Properties

**Molecular Formula**: Dapagliflozin — C21H25ClO6; Durvalumab — N/A.

**Molecular Weight**: Dapagliflozin — 408.8730 g/mol; Durvalumab — N/A.

**Type**: Dapagliflozin — Small molecule; Durvalumab — Antibody.